TY - DATA T1 - MOESM1 of Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial PY - 2016/08/26 AU - Takahiro Sawada AU - Hideo Tsubata AU - Naoko Hashimoto AU - Michinori Takabe AU - Taishi Miyata AU - Kosuke Aoki AU - Soichiro Yamashita AU - Shogo Oishi AU - Tsuyoshi Osue AU - Kiminobu Yokoi AU - Yasue Tsukishiro AU - Tetsuari Onishi AU - Akira Shimane AU - Yasuyo Taniguchi AU - Yoshinori Yasaka AU - Takeshi Ohara AU - Hiroya Kawai AU - Mitsuhiro Yokoyama UR - https://springernature.figshare.com/articles/journal_contribution/MOESM1_of_Effects_of_6-month_eicosapentaenoic_acid_treatment_on_postprandial_hyperglycemia_hyperlipidemia_insulin_secretion_ability_and_concomitant_endothelial_dysfunction_among_newly-diagnosed_impaired_glucose_metabolism_patients_with_coronary_artery_dis/4348037 DO - 10.6084/m9.figshare.c.3606221_D2.v1 L4 - https://ndownloader.figshare.com/files/7074086 KW - Eicosapentaenoic acid KW - Impaired glucose metabolism KW - Postprandial hyperglycemia KW - Postprandial insulin secretion KW - Postprandial hypertriglyceridemia KW - Endothelial dysfunction N2 - Additional file 1: Table S1. Multiple regression analysis for predicting incremental glucose peak improvement. ER -